drugset / Trial / NCT04865419
Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to the evaluate safety, tolerability, pharmacokinetics (PK), and efficacy of AZD0466 as monotherapy in partciapants with advanced haematological malignancies and also to assess drug-drug interaction (DDI) potential between AZD0466 and the azole antifungal voriconazole.
Timeline
- Start
- 2021-06-11
- Primary completion
- 2023-08-08
- Completion
- 2023-08-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD0466 | Unknown | — | Intravenous |
| Subject | Voriconazole | Small molecule | — | Oral |